Evidence map›Paper›PMID 31159606›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2019

Discovery and antitumor evaluation of novel inhibitors of spermine oxidase.

Lidan Sun, Jianlin Yang, Yu Qin, Yanlin Wang, Hongyan Wu, You Zhou, Chunyu Cao

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Targeted inhibition of eIF5ACell death & disease · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lidan Suna College of Chemical Engineering and Material Science , Quanzhou Normal University , Quanzhou , China.
Jianlin Yangb Hubei Key Laboratory of Tumour Microenvironment and Immunotherapy , China Three Gorges University Medical College , Yichang , China.
Yu Qinb Hubei Key Laboratory of Tumour Microenvironment and Immunotherapy , China Three Gorges University Medical College , Yichang , China.
Yanlin Wangb Hubei Key Laboratory of Tumour Microenvironment and Immunotherapy , China Three Gorges University Medical College , Yichang , China.
Hongyan Wub Hubei Key Laboratory of Tumour Microenvironment and Immunotherapy , China Three Gorges University Medical College , Yichang , China.
You Zhoub Hubei Key Laboratory of Tumour Microenvironment and Immunotherapy , China Three Gorges University Medical College , Yichang , China.
Chunyu Caob Hubei Key Laboratory of Tumour Microenvironment and Immunotherapy , China Three Gorges University Medical College , Yichang , China.
China Three Gorges University · CNQuanzhou Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing knowledge of the relationship between cancer and dysregulated polyamine catabolism suggests interfering with aberrant polyamine metabolism for anticancer therapy that will have considerable clinical promise. SMO (spermine oxidase) plays an essential role in regulating the polyamines homeostasis. Therefore, development of SMO inhibitors has increasingly attracted much attention. Previously, we successfully purified and characterised SMO. Here, we presented an in silico drug discovery pipeline by combining pharmacophore modelling and molecular docking for the virtual screening of SMO inhibitors. In vitro evaluation showed that

Indexed as

Drug DiscoveryDrug Screening Assays, AntitumorA549 CellsAntineoplastic AgentsApoptosisCell CycleCell ProliferationDose-Response Relationship, DrugEnzyme InhibitorsHumansModels, MolecularOxidoreductases Acting on CH-NH Group DonorsPolyamine OxidaseStructure-Activity RelationshipAntineoplastic AgentsEnzyme InhibitorsOxidoreductases Acting on CH-NH Group DonorsPolyamine Oxidaseantitumor activityQuinolinecarboxamidespermine oxidase

Identifiers

PMID31159606
PMCPMC6567099
OpenAlexW2948134990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.